Newsfeeds Archive - Page 2 of 3

2 minute read

Qualigen Therapeutics Divests FastPack Diagnostics Business

July 24, 8:17 AM

All cash deal with Chembio Diagnostics, a US Subsidiary of the French Diagnostics Company BIOSYNEX, SA, solidifies Qualigen's strategic priority on therapeutics CARLSBAD, Calif., July 24, 2023 (GLOBE NEWSWIRE) --

QLGN

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

July 21, 9:05 AM

Gainers Fresh Tracks Therapeutics (NASDAQ:FRTX) stock rose 35.2% to $0.92 during Friday’s pre-market session. The company’s market cap…

AIMD

6 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

March 29, 2:46 PM

On Wednesday, 81 companies hit new 52-week lows.

ADV

7 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

March 27, 1:22 PM

On Monday, 89 stocks made new 52-week lows.

ADN

3 minute read

Qualigen Therapeutics Provides Update On Developments At NanoSynex; Significant Progress Reported On Infectious Disease Diagnostic Platform

By Benzinga Newsdesk

January 5, 10:12 AM

Qualigen Therapeutics, Inc. (("Qualigen" or "the Company, NASDAQ:QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug

QLGN

1 minute read

News

Qualigen Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Rule

By Benzinga Newsdesk

December 12, 9:38 AM

Qualigen Therapeutics, Inc. ((&ldquo, Qualigen&rdquo, or &ldquo, the Company, &rdquo, NASDAQ:QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for

QLGN